Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.54
+0.47 (1.80%)
At close: Nov 6, 2026, 4:00 PM EST
27.20
+0.66 (2.49%)
After-hours: Nov 6, 2026, 7:30 PM EST
Stoke Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +88.39% | Nov 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $58 | Buy | Reiterates | $58 | +118.54% | Nov 2, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +46.95% | Nov 2, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +50.72% | Oct 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $44 → $43 | Buy | Maintains | $44 → $43 | +62.02% | Oct 30, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $60 | Buy | Reiterates | $60 | +126.07% | Oct 30, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $25 → $60 | Buy | Reiterates | $25 → $60 | +126.07% | Oct 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $40 | Buy | Initiates | $40 | +50.72% | Aug 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.